BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30923462)

  • 1. LATS2 overexpression attenuates the therapeutic resistance of liver cancer HepG2 cells to sorafenib-mediated death via inhibiting the AMPK-Mfn2 signaling pathway.
    Song J; Zhao W; Lu C; Shao X
    Cancer Cell Int; 2019; 19():60. PubMed ID: 30923462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LATS2 promotes cardiomyocyte H9C2 cells apoptosis via the Prx3-Mfn2-mitophagy pathways.
    Tian Y; Lv W; Lu C; Zhao X; Zhang C; Song H
    J Recept Signal Transduct Res; 2019; 39(5-6):470-478. PubMed ID: 31829064
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-tumor effect of LATS2 on liver cancer death: Role of DRP1-mediated mitochondrial division and the Wnt/β-catenin pathway.
    Zhang L; Li S; Wang R; Chen C; Ma W; Cai H
    Biomed Pharmacother; 2019 Jun; 114():108825. PubMed ID: 30981110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTEN inhibition attenuates endothelial cell apoptosis in coronary heart disease via modulating the AMPK-CREB-Mfn2-mitophagy signaling pathway.
    Li P; Wang J; Zhao X; Ru J; Tian T; An Y; Tang L; Bai Y
    J Cell Physiol; 2020 May; 235(5):4878-4889. PubMed ID: 31654396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large tumor suppressor kinase 2 overexpression attenuates 5-FU-resistance in colorectal cancer via activating the JNK-MIEF1-mitochondrial division pathway.
    Yao W; Zhu S; Li P; Zhang S
    Cancer Cell Int; 2019; 19():97. PubMed ID: 31011291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-2 augments the sorafenib-induced apoptosis in liver cancer by promoting mitochondrial fission and activating the JNK/TAZ pathway.
    Ding X; Sun W; Chen J
    Cancer Cell Int; 2018; 18():176. PubMed ID: 30459526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of macrophage stimulating 1 enhances the anti-tumor effects of IL-24 in esophageal cancer via inhibiting ERK-Mfn2 signaling-dependent mitophagy.
    Zhang J; Sun L; Li W; Wang Y; Li X; Liu Y
    Biomed Pharmacother; 2019 Jun; 114():108844. PubMed ID: 30981108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LATS2 promotes apoptosis in non-small cell lung cancer A549 cells via triggering Mff-dependent mitochondrial fission and activating the JNK signaling pathway.
    Xie Y; Lv Y; Zhang Y; Liang Z; Han L; Xie Y
    Biomed Pharmacother; 2019 Jan; 109():679-689. PubMed ID: 30551520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mfn2 Overexpression Attenuates Cardio-Cerebrovascular Ischemia-Reperfusion Injury Through Mitochondrial Fusion and Activation of the AMPK/Sirt3 Signaling.
    Liu M; Li X; Huang D
    Front Cell Dev Biol; 2020; 8():598078. PubMed ID: 33195281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retraction Note to: LATS2 overexpression attenuates the therapeutic resistance of liver cancer HepG2 cells to sorafenib‑mediated death via inhibiting the AMPK-Mfn2 signaling pathway.
    Song J; Zhao W; Lu C; Shao X
    Cancer Cell Int; 2019; 19():359. PubMed ID: 31892858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin-induced increase in sensitivity of human hepatocellular carcinoma cells to sorafenib is associated with reactive oxygen species production and mitophagy.
    Prieto-Domínguez N; Ordóñez R; Fernández A; Méndez-Blanco C; Baulies A; Garcia-Ruiz C; Fernández-Checa JC; Mauriz JL; González-Gallego J
    J Pineal Res; 2016 Oct; 61(3):396-407. PubMed ID: 27484637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High mobility group box 1 promotes sorafenib resistance in HepG2 cells and in vivo.
    Xiao Y; Sun L; Fu Y; Huang Y; Zhou R; Hu X; Zhou P; Quan J; Li N; Fan XG
    BMC Cancer; 2017 Dec; 17(1):857. PubMed ID: 29246127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sorafenib kills liver cancer cells by disrupting SCD1-mediated synthesis of monounsaturated fatty acids
    Liu G; Kuang S; Cao R; Wang J; Peng Q; Sun C
    FASEB J; 2019 Sep; 33(9):10089-10103. PubMed ID: 31199678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine augments the sorafenib-induced apoptosis in Huh7 liver cancer cell by inducing mitochondrial fragmentation and activating MAPK-JNK signalling pathway.
    Zhang L; Li S; Wang R; Chen C; Ma W; Cai H
    Biomed Pharmacother; 2019 Feb; 110():213-223. PubMed ID: 30476722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketoconazole exacerbates mitophagy to induce apoptosis by downregulating cyclooxygenase-2 in hepatocellular carcinoma.
    Chen Y; Chen HN; Wang K; Zhang L; Huang Z; Liu J; Zhang Z; Luo M; Lei Y; Peng Y; Zhou ZG; Wei Y; Huang C
    J Hepatol; 2019 Jan; 70(1):66-77. PubMed ID: 30287340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tanshinone IIA regulates colorectal cancer apoptosis via attenuation of Parkin‑mediated mitophagy by suppressing AMPK/Skp2 pathways.
    He L; Gu K
    Mol Med Rep; 2018 Aug; 18(2):1692-1703. PubMed ID: 29845197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TAZ inhibition promotes IL-2-induced apoptosis of hepatocellular carcinoma cells by activating the JNK/F-actin/mitochondrial fission pathway.
    Ji K; Lin K; Wang Y; Du L; Xu C; He N; Wang J; Liu Y; Liu Q
    Cancer Cell Int; 2018; 18():117. PubMed ID: 30127666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NR4A1 Promotes Cerebral Ischemia Reperfusion Injury by Repressing Mfn2-Mediated Mitophagy and Inactivating the MAPK-ERK-CREB Signaling Pathway.
    Zhang Z; Yu J
    Neurochem Res; 2018 Oct; 43(10):1963-1977. PubMed ID: 30136162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin enhances TNF-α-mediated cervical cancer HeLa cells death via suppressing CaMKII/Parkin/mitophagy axis.
    Zhao Q; Wang W; Cui J
    Cancer Cell Int; 2019; 19():58. PubMed ID: 30923460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effect of Sirtuin 3 on ameliorating nonalcoholic fatty liver disease: The role of the ERK-CREB pathway and Bnip3-mediated mitophagy.
    Li R; Xin T; Li D; Wang C; Zhu H; Zhou H
    Redox Biol; 2018 Sep; 18():229-243. PubMed ID: 30056271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.